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A 70-year-old woman with a recent diagnosis of
dermatomyositis (DM) presented to the dermatology
department for study of a probably paraneoplastic
syndrome. On examination, we observed discrete,
indurated, reddish, painful plaques and nodules on her
abdomen and both thighs. A cutaneous biopsy from an
abdominal nodule, performed as part of the paraneoplastic
workup, was suggestive of cutaneous lymphangitis
carcinomatosa, secondary to unknown malignancy. An
extensive investigation to locate the site of the primary
tumour revealed no specific findings. A course of palliative
chemotherapy with cisplatin and 5-fluorouracil was then
given, but the patient’s condition deteriorated and
6 months after her initial observation the patient died.
We describe this case because, to our knowledge, the
association between DM and cutaneous lymphangitis
carcinomatosa has not been described yet in the literature
and to highlight that, DM can be a rapidly lethal disease.
BACKGROUND
Dermatomyositis (DM) is an uncommon inflamma-
tory myopathy of unkown aetiology, characterised
by the association of progressive proximal muscle
weakness, pathognomonic or specific cutaneous
findings, and compatible electrophysiological and
pathological findings.1 2 The disease demonstrates a
bimodal age distribution in juvenile and adult
forms. In adults, it is often considered as a paraneo-
plastic syndrome.3
We present a case of rapidly lethal paraneoplastic
DM, associated with cutaneous lymphangitis
carcinomatosa, without a definitive diagnosis of the
primary tumour.
CASE PRESENTATION
A previously healthy 70-year-old Caucasian woman
was admitted to our department with heliotrope
erythema, periorbital swelling, several proximal
muscle weaknesses and painful nodules on her
abdomen and thighs. All of these lesions appeared
progressively over the previous 6 months. The
patient presented with asthenia anorexia and weight
loss of 8 kg in 5 months. She also reported dyspha-
gia, mainly at the initiation of the attempt and
disphony. Her medical and family histories were
unremarkable. She was not taking any medication.
A physical examination revealed discrete, indu-
rated, reddish, painful plaques and nodules on her
upper abdomen and both thighs (figures 1 and 2).
The nodules were well circumscribed, firm and non-
mobile, with diameters ranging from 6 mm to 5 cm.
There were no other abnormalities on examination.
We also observed pink/violet macular hyperpig-
mentation and atrophy, with telangiectasias over the
posterior shoulders, back, buttocks and a V-shaped
area of the anterior neck and chest, suggestive of poi-
kiloderma. Evaluation of muscle strength revealed a
grade 4/5 weakness of the pectoral and pelvic girdle
musculature. The laboratory tests revealed erythrocyte
sedimentation rate 63 mm/h (normal range 1–20),
creatine kinase 440 UI/L (normal range 26–192),
lactate dehydrogenase 254 UI/L (normal range 84–
246), normocytic and normochromic anaemia with
haemoglobin 8.2 g/dL and platelet count 29×109/L.
The serum levels of cancer antigen 125 (CA125), CA
19.9, CA 15.3, and carcinoembryonic antigen were
61.70 U/mL (normal <35), 7.50 (normal range <37),
33.50 U/mL (normal range <32.4) and 5 U/mL
(normal range 0.0–5) ng/mL, respectively. Antinuclear
antibodies, anti-Jo-1 antibody, antiribonucleoprotein
antibody, and anti-Ro antibody were negative.
A deltoid muscle biopsy revealed perivascular and
interfascicular inflammatory infiltrates with adjoining
groups of muscle fibre degeneration/regeneration,
suggestive of DM. Electromyography was suggestive
of a myopathic pattern with multiple polyphasic
low-amplitude potentials with sharp edges and
short duration.
Figure 1 Reddish, indurated plaques and nodules on
her upper abdomen.
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Taken together, clinical, laboratory and pathological data sug-
gested the diagnosis of a paraneoplastic DM, without a known
malignancy.
The patient was initially treated with prednisone (60 mg orally
daily) and the dose was gradually reduced over many weeks to
months. She also received hydroxychloroquine (400 mg orally
daily) and azathioprine (100 mg orally daily), with only partial
response. The patient underwent extensive investigation to locate
the site of the primary tumour, including chest x-ray, CT of the
chest, abdomen and pelvis, oesophagogastroscopy, colonoscopy
and mammography. This extensive workup revealed no specific
findings. A cutaneous biopsy from an abdominal nodule,
performed as part of the paraneoplastic workup, to exclude
skin metastasis, demonstrated an infiltration of the dermal and
hypodermal lymphatics by neoplastic cells (figure 3).
Immunohistochemistry reports were positive for cytokeratin 7
(CK7; figure 4) and negative for CK20 and thyroid transcription
factor-1 (TTF-1), or oestrogen receptors. Diagnosis of cutaneous
lymphangitis carcinomatosa, secondary to unknown malignancy
was made.
TREATMENT
A course of palliative chemotherapy with cisplatin and
5-fluorouracil was given to the patient after the diagnosis of
cutaneous lymphangitis carcinomatosa.
OUTCOME AND FOLLOW-UP
The patient’s condition deteriorated and 6 months after her
initial observation, the patient succumbed with Gram-negative
sepsis, which failed to respond to treatment with broad-spectrum
antibiotics. A postmortem examination was not performed.
DISCUSSION
DM is related to an increased risk of cancer and is often considered
as a paraneoplastic syndrome, although the strength of this relation-
ship and its predisposing factors are not clearly defined.3–6 This
association is more frequently seen in adults with DM rather than
in the paediatric population.7 8 The reported frequency of an
internal malignancy in adults above the age of 40 years with DM
has been reported in the range 10–50%.6 9
The malignancies, most strongly associated with DM include
the malignancy of gastrointestinal tract, pancreas, lung, breast,
gynaecological cancers and non-Hodgkin’s lymphoma.6 7 10
Cutaneous manifestations seen in paraneoplastic DM are
similar to those of classic DM and include a heliotropic rash
with periorbital oedema, nail fold telangiectasias, Gottron’s
papules on the finger joints and pink-violaceous poikiloderma
overlying the chest, upper back, elbows and knees.8
Autoantibodies are present in a high percentage of patients with
DM without malignancy and the absence of autoantibodies may
be predictive of an occult malignancy,8 like in our patient.
The malignancy can occur before the onset of DM, concomi-
tantly or afterwards.1 9 In our patient, the malignancy appears a
few months after the initial symptoms of DM, but this temporal
relation is not clear in our case. In 5–10% of malignancies, the
primary tumour is not known, despite full evaluation, and they
first appear in one or more metastatic sites,6 like in our patient.
Management of paraneoplastic DM focuses primarily on
the treatment of DM and the underlying malignancy.8
Paraneoplastic DM is generally more resistant to corticosteroids
and cytotoxic therapies, compared with idiopathic DM.2 6
Moreover, the immunosuppressive drugs that are used in the
Figure 3 Infiltration of the dermal and hypodermal lymphatics by
neoplastic cells. Figure 4 Tumour cells are positive for cytokeratin 7.
Figure 2 Reddish, indurated plaques and nodules on both her thighs.
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treatment of DM could theoretically exacerbate malignancy, but
this is seldom seen in clinical practice.4 5 8
Cutaneous lymphangitis carcinomatosa, a type of cutaneous
metastasis, was also diagnosed in our patient.
Cutaneous metastasis of cancer is rare.11–13 The incidence of
cutaneous metastasis in patients with metastatic cancer is
approximately 5% and the skin represents the 12th site of
metastasis for deep cancer.11–13
Cutaneous lymphangitis carcinomatosa is a rare presentation
of skin metastasis, accounting for approximately 5% of all cuta-
neous metastasis and it results from an occlusion of the lymph-
atic channels of the dermis by neoplastic cells.11
The prognosis of cutaneous lymphangitis carcinomatosa is
very poor with a mean survival of 3 months after diagnosis of
cutaneous deposits.12 13
Our patient died 4 months after the diagnosis of cutaneous
lymphangitis carcinomatosa. There are few published cases of
cutaneous lymphangitis carcinomatosa and, to our knowledge,
this is the first case of cutaneous lymphangitis carcinomatosa
associated with paraneoplastic DM.11–13
Immunohistopathological stains showed a cytokine expression
profile (CK7 positive and negative for CK20, TTF-1 or oestro-
gen receptors). Our findings in immunohistochemistry favour
the hypothesis of a gastric carcinoma. However, the hypothesis
of breast cancer with loss of oestrogen receptor cannot be
excluded. These results make the hypothesis of pulmonary car-
cinoma unlikely.
The patient’s condition deteriorated rapidly and the patient
died without a diagnosis of the primary tumour.
We describe this case because the association between DM
and cutaneous lymphangitis carcinomatosa is rare and to high-
light that DM can be a rapidly lethal disease.
Learning points
▸ The absence of autoantibodies in dermatomyositis (DM) may
be predictive of an occult malignancy.
▸ Paraneoplastic DM can be a rapidly lethal disease.
▸ Cutaneous lymphangitis carcinomatosa is a rare presentation
of skin metastasis, accounting for approximately 5% of all
cutaneous metastasis.
▸ The prognosis of cutaneous lymphangitis carcinomatosa is
very poor with a mean survival of 3 months after diagnosis
of cutaneous deposits.
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